Table 4.

Lipid profile: concentrations and ratios, by MS status and particle size phenotype (N = 185)

	No SM (N = 72)			SM (N = 113)
	Phenotype A (> 260 Å)	Phenotype B (≤ 260 Å)	p-value	Phenotype A (> 260 Å)	Phenotype B (≤ 260 Å)	p-value
Plasma cholesterol (mg/dL)	188 ± 35.9	245 ± 56	0.103	196.1 ± 83.6	227 ± 48	0.009*
Plasma triglycerides (mg/dL)	101 [70-129.3]	282 [265-298]	0.003*	129 [91-195]	245 [178-296]	> 0.001*
LDL cholesterol (mg/dL)	106.4 ± 31.8	137 ± 54	0.379	112 ± 34	124 ± 32	0.151
HDL cholesterol (mg/dL)	60 [52-69]	52 [47-56]	0.329	53 [41-63]	42 [38-52]	0.072
Apo A-I (mg/dL)	160.6 ± 22.1	168 ± 4.24	0.538	159.37 ± 31.7	158.7 ± 26.5	0.270
Apo A-II (mg/dL)	31 [28-33]	36.5 [35-38]	0.069	32 [27-38]	34 [30-41]	0.934
Apo B (mg/dL)	95.4 ± 23.1	139 ± 24.1	0.025*	105.1 ± 21.4	122.5 ± 31.2	0.014*
Lipoprotein (a) (mg/dL)	18.6 [4.9-43]	1.25 [1.2-1.3]	0.005*	14.3 [4.2-33.7]	19.5 [12.9-47.3]	0.844
Apo B/Apo A-I ratio	0.60 ± 0.16	0.83 ± 0.12	0.050*	0.69 ± 0.19	0.78 ± 0.18	0.023
Plasma cholesterol/HDL-c ratio	3.22 ± 0.84	4.72 ± 0.50	0.016*	3.84 ± 1.18	4.82 ± 1.17	0.001
Plasma triglycerides/HDL-c ratio	1.65 [1.13-2.45]	5.55 [4.73-6.34]	0.003*	2.49 [1.53-3.67]	5.49 [3.99-6.85]	> 0.001*
Log (TG/HDL-c) ratio	0.20 ± 0.24	0.74 ± 0.08	0.003*	0.38 ± 0.29	0.72 ± 0.19	> 0.001*
LDL particle size (Å)	273.6 [271.1-274.7]	255.25 [255-255.5]	0.001*	271.2 [267.7-273.7]	259 [257.6-260]	> 0.001*

Notes: Data are mean ± SD, and median and interquartile range. * Statistically significant differences.

p-value¹: significance between phenotype MS in non-MS patients.

p-value²: significance between phenotype MS in MS patients.

p-value³: significance between MS status.